U
ASTX

UBS’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

UBS’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-205,100
Closed -$1.74M – 11357
2013
Q3 		$1.74M Buy
205,100
+181,400
+765% +$1.15M ﹤0.01% 2732
2013
Q2 		$97K Buy
+23,700
New +$127K ﹤0.01% 5954

UBS's ASTX Position: Q4 2013 in Review

UBS sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 140,305 shares — an estimated $1.19M sold.

UBS first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $1.19M in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • UBS reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • UBS sold 140,305 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $1.19M.
  • UBS first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • UBS's ASTEX PHARMACEUTICALS, INC COM position peaked at $1.19M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.